November 15th 2024
The algal EPA+DHA ingredient expands on the company's existing algal omega-3 portfolio which was DHA only.
Hofseth BioCare partners with Catalent to develop delayed-release fish oil capsules
May 18th 2021A Norwegian biotech company, Hofseth BioCare ASA, has entered into a global innovation partnership with Catalent to develop a delayed-release formulation of Hofseth’s OmeGo fish oil, derived from sustainable, traceable, and fresh Norwegian Atlantic salmon.
GOED and ClearCut Analytics to host webinar on EPA-DHA products selling on Amazon
April 6th 2021The Global Organization for EPA and DHA Omega-3s (GOED) and ClearCut Analytics are hosting a 30-minute webinar on the U.S. EPA and DHA supplement category on Amazon on Thursday, April 29, 2021 at 9 a.m. PDT/12 p.m. EDT.
GOED releases its 2020 Annual Report
March 26th 2021The Global Organization for EPA and DHA Omega-3s released its 2020 Annual Report detailing the organization’s accomplishments, financial health, and progress on strategic objectives from the previous year. The report also includes the organization’s five-year strategic plan.
GOED and SNP announce partnership, making 11 Peruvian fisheries GOED members
March 2nd 2021Under the agreement, 11 key Peruvian fishing companies, all of which are SNP members, will become members of GOED. The partnership acknowledges the key role the Peruvian anchovy fishery plays in the omega-3 industry.
Study demonstrates high bioavailability of AvailOm omega-3 lysine complex
February 9th 2021A recent study demonstrated the bioavailability of Evonik’s AvailOm omega-3 lysine complex. The novel technology combines omega-3 fatty acids with the amino acid L-lysine to enhance the absorption of omega-3s in the body.
Pilot study finds potential link between omega-3 levels and COVID-19 mortality
January 15th 2021Researchers with the Fatty Acid Research Institute, in collaboration with Cedars-Sinai Medical Center in Los Angeles, CA, recently posted the results of a pilot study which found a potential link between low Omega-3 Index levels and mortality from COVID-19 infection.
Qualitas Health secures $10 million in venture funds to commercialize new plant protein
January 14th 2021The investment will help accelerate customer acquisition and commercialization of the company’s unique plant-based protein, as well as deepen the clinical science and intellectual property to accelerate its expansion into additional geographies.
Aker to collaborate with University of Illinois Chicago, securing IP rights for LPC-bound EPA/DHA
January 6th 2021As part of their collaboration, Aker has entered into an exclusive licensing agreement with University of Illinois Chicago for the current intellectual property resulting from the University's work on LPC-bound EPA and DHA.
Synergistic formula supports inflammatory markers and blood pressure, says recent study
September 22nd 2020A recent study found a synergistic supplement formula containing mixed tocotrienols, curcumin, omega-3s, astaxanthin, and other nutrients significantly reduced inflammatory markers and systolic blood pressure in healthy subjects.